Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation

被引:0
|
作者
Akram, Muhammad [1 ]
Naqvi, Syed Baqir Shyum [1 ]
Khan, Ahmad [1 ]
机构
[1] Univ Karachi, Fac Pharm, Dept Pharmaceut, Karachi 32, Pakistan
关键词
Insulin delivery; factorial design; Emu Oil; transdermal emulgel; drug release kinetics and iontophoresis; PENETRATION ENHANCERS; PERCUTANEOUS PENETRATION; HUMAN-SKIN; RAT SKIN; OLEIC-ACID; PERMEATION; IONTOPHORESIS; PERMEABILITY; PRETREATMENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of the present study was to formulate an insulin emulgel, selection of an optimize formulation through in vitro drug release kinetics and finally evaluate its hypoglycemic activity in animal model. Insulin emulgel was prepared using Emu Oil as penetration enhancer with the combination of Carbomer or Hydroxypropyl Methylcellulose (HPMC) as gelling agent and Polysorbate 80 as emulsifier. The response of gelling agent type (Carbomer or HPMC) and concentration of other two variables penetration enhancer and emulsifier were studied using 2(3) factorial design during in vitro drug release through excised rat skin. Biological. activity of emulgel formulation was also investigated using Albino rabbits alone and in combination with iontophoresis. The in vivo efficacy of insulin emulgel was assessed by measuring the blood glucose level at start of the experiment and after every 15 minutes interval for 120 minutes. Total eight formulations were studied. F4 formulation showed maximum insulin permeation flux (4.88 +/- 0.09 mu g/cm(2)/hour) through excised rat skin. Insulin permeation from these formulations was found to follow the Korsmeyer-Peppas model (r(2)=0.975 to 0.998) during 24 hour with non-Fickian mechanism. Formulation F4 was further investigated in Albino rabbits. For the first group (treated with insulin emulgel alone) the blood glucose level decreased from initial value 250 +/- 10mg/dl to 185 +/- 7 +/- mg/dl at 120 minutes and for the second group (treated with insulin emulgel plus iontophoresis) the blood glucose level decreased to 125 +/- 5mg/dl in 120 minutes (P<0.05). It was observed that absorption of insulin through transdermal emulgel was greater in combination with iontophoresis to decrease blood glucose level. On the basis of this study, it has been shown that application of insulin emulgel iontophoretically can be used as alternative (acceptable & painless) to injectable insulin subject to further studies on large animals.
引用
收藏
页码:323 / 332
页数:10
相关论文
共 50 条
  • [1] Formulation and Evaluation of Bisoprolol Hemifumarate Emulgel for Transdermal Drug Delivery
    Gul, Rahman
    Khan, Yasmin
    Aman, Tajala
    [J]. DISSOLUTION TECHNOLOGIES, 2022, 29 (01): : 38 - 44
  • [2] Formulation Design and Evaluation of an Emulgel Containing Terminalia arjuna Bark Extract for Transdermal Delivery
    Gaikwad, Dinanath Tukaram
    Jadhav, Namdeo Ramhari
    [J]. PHARMACOGNOSY MAGAZINE, 2018, 14 (55) : S249 - S255
  • [3] Vesicular Emulgel Based System for Transdermal Delivery of Insulin: Factorial Design and in Vivo Evaluation
    Shehata, Tamer M.
    Nair, Anroop B.
    Al-Dhubiab, Bandar E.
    Shah, Jigar
    Jacob, Shery
    Alhaider, Ibrahim A.
    Attimarad, Mahesh
    Elsewedy, Heba S.
    Ibrahim, Mahmoud M.
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (15):
  • [4] DESIGN, FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF BUDESONIDE
    Amgaokar, Yogesh M.
    Chikhale, Rupesh V.
    Lade, Updesh B.
    Biyani, Dinesh M.
    Umekar, Milind J.
    [J]. DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2011, 6 (02) : 475 - 497
  • [5] Transdermal drug delivery: Vehicle design and formulation
    Pefile, S
    Smith, EW
    [J]. SOUTH AFRICAN JOURNAL OF SCIENCE, 1997, 93 (04) : 147 - 150
  • [6] DESIGN, DEVELOPMENT AND EVALUATION OF TRANSDERMAL DRUG DELIVERY OF CAPTOPRIL, AN ANTIHYPERTENSIVE DRUG
    Khaja, Md.
    Syed, Muneer
    Rao, D. Srinivasa
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 1 (05): : 305 - 314
  • [7] Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride
    Akram, Muhammad Rouf
    Ahmad, Mahmood
    Abrar, Asad
    Sarfraz, Rai Muhammad
    Mahmood, Asif
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 349 - 364
  • [8] Development of Transdermal Formulation Based on Nanotechnology and Elucidation of Its Drug Delivery Pathways
    Otake, Hiroko
    Nagai, Noriaki
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (05): : 505 - 510
  • [9] FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY OF RALOXIFENE HYDROCHLORIDE
    Chauhan, Iti
    Bajpai, Meenakshi
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (12): : 72 - U4521
  • [10] DEVELOPMENT OF A NOVEL FORMULATION FOR TRANSDERMAL DELIVERY OF AN ANTIDEPRESSANT DRUG
    Negi, Purnima
    Ahmad, Farhan J.
    Ahmad, Dabeer
    Jain, Gaurav K.
    Singh, Gyanendra
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (07): : 1766 - 1771